PDCD1 and deltaretrovirus infections: A combined approach including the injection of meloxicam (a COX-2 inhibitor) and an antibody against PD-1 led to a considerably reduced BLV virus load, suggesting that it might function as a novel and efficient preventative intervention against BLV infection.